Parenteral Drugs (India) Ltd. - Research Center
PARENTLD Group (Z) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Sales | 1.77 | 1.44 | 2.35 | 2.93 | 2.57 |
| Operating profit | -5.88 | -3.22 | -3.27 | -2.63 | 3.39 |
| Interest | - | 36.68 | 35.47 | 34.10 | 32.46 |
| Gross profit | -5.85 | -39.90 | -38.72 | -36.72 | -29.04 |
| EPS (Rs) | 7.99 | -11.58 | -11.27 | -10.74 | -8.33 |
Quarterly
results in details
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Other income | 0.04 | 0.01 | 0.01 | 0.01 | 0.03 |
| Stock adjustment | -0.43 | 0.02 | 0.31 | 0.66 | 0.21 |
| Raw material | 2.19 | 0.57 | 1.16 | 0.99 | 0.71 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 3.78 | 3.64 | 3.67 | 3.70 | 1.54 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2.12 | 0.43 | 0.49 | 0.22 | -3.28 |
| Provisions made | - | - | - | - | - |
| Depreciation | 27.15 | 4.33 | 4.33 | 4.33 | 4.32 |
| Taxation | -4.60 | -9.70 | -9.44 | -9.02 | -8.51 |
| Net profit / loss | 23.81 | -34.52 | -33.61 | -32.04 | -24.84 |
| Extra ordinary item | 52.21 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 29.82 | 29.82 | 29.82 | 29.82 | 29.82 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -331.90 | -223.59 | -139.08 | -89.90 | 131.99 |
| GPM (%) | -322.51 | -2745.65 | -1640.06 | -1248.42 | -1118.49 |
| NPM (%) | 1313.64 | -2375.95 | -1423.63 | -1089.16 | -956.82 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis